Cite
Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.
MLA
Bestehorn H, et al. “Evaluation of the Effect of Oral Verapamil on Clinical Outcome and Angiographic Restenosis after Percutaneous Coronary Intervention: The Randomized, Double-Blind, Placebo-Controlled, Multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.” Journal of the American College of Cardiology (JACC), vol. 43, no. 12, June 2004, pp. 2160–65. EBSCOhost, https://doi.org/10.1016/j.jacc.2004.02.047.
APA
Bestehorn H, Neumann F, Büttner HJ, Betz P, Stürzenhofecker P, von Hodenberg E, Verdun A, Levai L, Monassier JP, Roskamm H, Bestehorn, H.-P., Neumann, F.-J., Büttner, H. J., Betz, P., Stürzenhofecker, P., von Hodenberg, E., Verdun, A., Levai, L., Monassier, J. P., & Roskamm, H. (2004). Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial. Journal of the American College of Cardiology (JACC), 43(12), 2160–2165. https://doi.org/10.1016/j.jacc.2004.02.047
Chicago
Bestehorn H, Neumann F, Büttner HJ, Betz P, Stürzenhofecker P, von Hodenberg E, Verdun A, et al. 2004. “Evaluation of the Effect of Oral Verapamil on Clinical Outcome and Angiographic Restenosis after Percutaneous Coronary Intervention: The Randomized, Double-Blind, Placebo-Controlled, Multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.” Journal of the American College of Cardiology (JACC) 43 (12): 2160–65. doi:10.1016/j.jacc.2004.02.047.